151 related articles for article (PubMed ID: 181954)
1. [Incidence and clinical features of pituitary tumours in cases of central Cushing's syndrome (author's transl)].
Barwich D
Acta Neurochir (Wien); 1976; 33(3-4):241-7. PubMed ID: 181954
[TBL] [Abstract][Full Text] [Related]
2. Chromophobe adenomas of the pituitary gland in Cushing's disease.
Lindholm J; Rasmussen P; Korsgaard O
Acta Endocrinol (Copenh); 1969 Dec; 62(4):647-52. PubMed ID: 4311983
[No Abstract] [Full Text] [Related]
3. Pituitary Cushing's disease arising from a previously non-functional corticotrophic chromophobe adenoma.
Vaughan NJ; Laroche CM; Goodman I; Davies MJ; Jenkins JS
Clin Endocrinol (Oxf); 1985 Feb; 22(2):147-53. PubMed ID: 2985300
[TBL] [Abstract][Full Text] [Related]
4. Cushing's disease in a patient with an ectopic pituitary adenoma.
Kammer H; George R
JAMA; 1981 Dec; 246(23):2722-4. PubMed ID: 6273604
[No Abstract] [Full Text] [Related]
5. A bromocriptine-responsive corticotroph adenoma secreting alpha-MSH in a patient with Cushing's disease.
Hale AC; Coates PJ; Doniach I; Howlett TA; Grossman A; Rees LH; Besser GM
Clin Endocrinol (Oxf); 1988 Feb; 28(2):215-23. PubMed ID: 2844447
[TBL] [Abstract][Full Text] [Related]
6. [Pituitary tumors and Cushing's syndrome].
Bricaire H; Luton JP; Turpin G
Nouv Presse Med; 1973 Feb; 2(8):499-502. PubMed ID: 4347601
[No Abstract] [Full Text] [Related]
7. [Immunocytochemical similarities between basophilic and chromophobe pituitary adenomas. Light and electron microscopic study of 13 cases (author's transl)].
Hassoun J; Charpin C; Jaquet P; Oliver C; Lissitzky JC; Grisoli F; Toga M
Ann Endocrinol (Paris); 1979; 40(6):559-60. PubMed ID: 232835
[TBL] [Abstract][Full Text] [Related]
8. The effect of ovine corticotrophin releasing factor (oCRF), bromocriptine and TRH on the secretion of ACTH and alpha-MSH in Nelson's syndrome and Cushing's disease.
Abraham RR; Campbell EA; Gillham B; Thody AJ; Altaher AR; Prysor-Jones A; Wynn V; Jones MT; Jenkins J
Clin Endocrinol (Oxf); 1986 Jul; 25(1):75-85. PubMed ID: 3024873
[TBL] [Abstract][Full Text] [Related]
9. Amenorrhea-galactorrhea associated with Cushing's disease due to pituitary tumor.
Rodriguez S; Alger M; Forsbach G; Contreras SN; Canales ES; Zarate A
J Endocrinol Invest; 1981; 4(1):37-40. PubMed ID: 6263966
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
[TBL] [Abstract][Full Text] [Related]
11. Eye signs in patients with Cushing's syndrome and pituitary tumors.
Rovit RL; Duane TD
Arch Ophthalmol; 1968 May; 79(5):512-22. PubMed ID: 4296395
[No Abstract] [Full Text] [Related]
12. The role of octreotide (Sandostatin) in non-growth hormone-, non-thyroid-stimulating hormone-, and non-prolactin-secreting adenomas.
Warnet A
Metabolism; 1992 Sep; 41(9 Suppl 2):59-61. PubMed ID: 1325596
[TBL] [Abstract][Full Text] [Related]
13. ACTH, beta-LPH and beta-endorphin in pituitary adenomas of the patients with Cushing's disease: activation of beta-LPH conversion to beta-endorphin.
Suda T; Abe Y; Demura H; Demura R; Shizume K; Tamahashi N; Sasano N
J Clin Endocrinol Metab; 1979 Sep; 49(3):475-7. PubMed ID: 224076
[TBL] [Abstract][Full Text] [Related]
14. [On the ocular manifestations of Cushing's syndrome with pituitary tumor].
Brégeat P; Caquet N; Girard P; Hamard H; Luton JP; Jolly J; Bricaire H
Bull Soc Ophtalmol Fr; 1969 Feb; 69(2):149-54. PubMed ID: 5400720
[No Abstract] [Full Text] [Related]
15. Cushing's disease in a patient with a 'nonfunctioning' pituitary tumor. Spontaneous development and remission.
Gogel EL; Salber PR; Tyrrell JB; Rosenblum ML; Findling JW
Arch Intern Med; 1983 May; 143(5):1040-2. PubMed ID: 6089681
[TBL] [Abstract][Full Text] [Related]
16. Chromophobe adenoma of the pituitary with Cushing's syndrome and skin pigmentation.
Sterling N; Hall MR
Postgrad Med J; 1979 Sep; 55(646):564-6. PubMed ID: 514937
[TBL] [Abstract][Full Text] [Related]
17. Metyrapone pre-treated inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome.
Cuneo RC; Lee W; Harper J; Mitchell K; Ward G; Atkinson RL; Salkield I; Cameron DP
Clin Endocrinol (Oxf); 1997 May; 46(5):607-18. PubMed ID: 9231057
[TBL] [Abstract][Full Text] [Related]
18. Differences in secretion characteristics in Cushing's disease with and without radiologically evident pituitary tumors.
Lamberts SW; Klijn JG; de Jong FH; Birkenhäger JC
J Endocrinol Invest; 1980; 3(3):257-62. PubMed ID: 6253556
[TBL] [Abstract][Full Text] [Related]
19. Pituitary pro-opiomelanocortin-cell carcinoma occurring in conjunction with a glioblastoma in a patient with Cushing's disease and subsequent Nelson's syndrome.
Gabrilove JL; Anderson PJ; Halmi NS
Clin Endocrinol (Oxf); 1986 Aug; 25(2):117-26. PubMed ID: 3024876
[TBL] [Abstract][Full Text] [Related]
20. Eye signs in patients with Cushing's syndrome and pituitary tumors: some observations related to chromophobe tumors and hyperadrenalism.
Rovit RL; Duane TD
Trans Am Ophthalmol Soc; 1967; 65():52-93. PubMed ID: 5299904
[No Abstract] [Full Text] [Related]
[Next] [New Search]
